<DOC>
	<DOCNO>NCT01819285</DOCNO>
	<brief_summary>Objectives I . Compare , randomize Phase III multi-institutional setting , symptom-free survival time patient asymptomatic carcinoma prostate ( T0-4 , N0-2 , M0 ) suit local curative treatment randomly assign immediate vs. delay endocrine intervention ( orchiectomy luteinizing hormone release hormone ( LHRH ) agonist therapy ) . II . Compare overall survival two group patient . III . Compare time first evidence distant progression ( N4 M1 ) two treatment group . IV . Evaluate prognostic significance pretreatment laboratory data monitor parameter follow endocrine therapy . V. Study prognosis various sub-groups patient stratify accord performance status , local tumor extent , nodal status , choice endocrine treatment .</brief_summary>
	<brief_title>Early Compared With Delayed Hormone Therapy Treating Patients With Nonmetastatic Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<criteria>Histologically cytologically proven , newly diagnose asymptomatic ( exception void disturbance ) carcinoma prostate T04 N02 M0 suitable local treatment curative intent ( radical prostatectomy , radiation therapy ) . All T stage acceptable ( UICC 1982 ) . The stage determine rectal palpation . Patients regional lymph node metastases small 5 cm ( N02 ) , determine either CT ultrasonography , preferable cytologic confirmation . Life expectancy least six month . WHO performance status score 01 . Informed consent . Patients must prepare undergo orchiectomy continuous treatment depot LHRH analogue . Continuous followup death possible . Other malignancy diagnose last 10 year , apart treat basal cell carcinoma skin . Prostate cancer know longer one month enter study . Pain cause prostate cancer metastasis . Any previous treatment prostate cancer ( radical prostatectomy , radiation therapy , endocrine treatment , etc . ) Note : TURP void disturbance allow time exclusion criterion . Patients ureteric obstruction cause local infiltration prostatic cancer evidence locally advanced disease could cause fatal complication untreated ( e.g . rectal stenosis , thrombosis pelvic vein ) . Patients palpable juxtaregional lymph node metastasis ( paraaortic , supraclavicular , inguinal , N34 ) . Patients evidence distant metastasis ( bone , lung , liver ) . Age 80 year . Performance status WHO score 2 , 3 4 ( reason ) . Patient refuse orchiectomy longterm subcutaneous implant LHRH analogue two monthly interval . Expected difficulty followup reason .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Malignant Neoplasm Prostate</keyword>
	<keyword>Tumor-node-metastasis ( TNM ) Staging Regional Lymph Nodes ( N0-2 )</keyword>
	<keyword>Not suitable local treatment curative intent</keyword>
</DOC>